The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
IVT, CL and TEL stand out as dividend growers, boosting payouts as inflation, Fed pause and Middle East tensions rattle markets.
Chilton Investment Co. Inc. acquired a new position in Colgate-Palmolive Company (NYSE: CL) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 7,670 shares of the company's stock, valued at approximately $613,000. Other hedge funds have also recently made changes to
California Public Employees Retirement System lessened its position in shares of Colgate-Palmolive Company (NYSE: CL) by 27.4% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,568,549 shares of the company's stock after selling 968,287 shares during the quarter. California Public
Ameriprise Financial Inc. boosted its stake in shares of Colgate-Palmolive Company (NYSE: CL) by 5.1% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,423,764 shares of the company's stock after purchasing an additional 314,584 shares during the quarter. Ameriprise Financial Inc.
Glenmede Investment Management LP grew its position in Colgate-Palmolive Company (NYSE: CL) by 17.6% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 480,609 shares of the company's stock after purchasing an additional 71,762 shares during the quarter. Glenmede Investment Management
FORA Capital LLC boosted its position in Colgate-Palmolive Company (NYSE: CL) by 161.2% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 59,696 shares of the company's stock after buying an additional 36,844 shares during the period. Colgate-Palmolive makes up approximately
Arrowstreet Capital Limited Partnership reduced its stake in Colgate-Palmolive Company (NYSE: CL) by 18.1% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,358,971 shares of the company's stock after selling 1,185,137 shares during the period. Arrowstreet Capital Limited
CL bets on science-led innovation, Colgate Total relaunch and AI-driven marketing to revive demand and boost premium growth across oral care and pet nutrition.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Investors love dividend stocks because they provide dependable passive income streams and an excellent opportunity for solid total return.
CL and PG stack up on growth, margins and valuation as estimates, pricing power and category focus shape their outlooks.